Efficacy of atomoxetine plus oxybutynin in the treatment of obstructive sleep apnea with moderate pharyngeal collapsibility.

Schweitzer, Paula K; Maynard, James P; Wylie, Paul E; Emsellem, Helene A; Sands, Scott A

Efficacy of atomoxetine plus oxybutynin in the treatment of obstructive sleep apnea with moderate pharyngeal collapsibility.

Schweitzer, Paula K; Maynard, James P; Wylie, Paul E; Emsellem, Helene A; Sands, Scott A.

Afiliação

Schweitzer PK; Sleep Medicine and Research Center, St. Luke's Hospital, 232 South Woods Mill Road, Chesterfield, MO, 63017, USA. paula.schweitzer@stlukes-stl.com.
Maynard JP; CTI Clinical Trial and Consulting, Cincinnati, OH, USA.
Wylie PE; Arkansas Center of Sleep Medicine, Little Rock, AR, USA.
Emsellem HA; The Center for Sleep & Wake Disorders, Chevy Chase, MD, and Department of Neurology (Clinical Faculty), George Washington University Medical Center, Washington, DC, USA.
Sands SA; Division of Sleep and Circadian Disorders, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Sleep Breath ; 27(2): 495-503, 2023 05.

Article em En | MEDLINE | ID: mdl-35551600

Assuntos

Apneia Obstrutiva do Sono; Humanos; Cloridrato de Atomoxetina/farmacologia; Cloridrato de Atomoxetina/uso terapêutico; Estudos Cross-Over; Sono

Palavras-chave

AD036; Atomoxetine; OSA pharmacotherapy; Obstructive sleep apnea; Oxybutynin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Apneia Obstrutiva do Sono Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google